CoChat
Sign Up
Cited by 94

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition

Hellner, Karin, Mar, Jessica, Fang, Frank, Quackenbush, John, Münger, Karl·2009·Virology
DOI 10.1016/j.virol.2009.05.036PMC PMC2728214
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.virol.2009.05.036

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 51

  1. Arima, 2008, Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition, Cancer Res., 68, 5104, 10.1158/0008-5472.CAN-07-5680 · DOI
  2. Boyer, 1996, E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway, Cancer Res., 56, 4620
  3. Brazma, 2001, Minimum information about a microarray experiment (MIAME)-toward standards for microarray data, Nat. Genet., 29, 365, 10.1038/ng1201-365 · DOI · Paper page
  4. Caberg, 2008, Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes, Carcinogenesis, 29, 1441, 10.1093/carcin/bgn145 · DOI
  5. Chamulitrat, 2003, Epithelium and fibroblast-like phenotypes derived from HPV16 E6/E7-immortalized human gingival keratinocytes following chronic ethanol treatment, Eur. J. Cell. Biol., 82, 313, 10.1078/0171-9335-00317 · DOI
  6. Chen, 2003, E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours, Eur. J. Cancer, 39, 517, 10.1016/S0959-8049(02)00175-2 · DOI
  7. Derycke, 2004, N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling, Int. J. Dev. Biol., 48, 463, 10.1387/ijdb.041793ld · DOI
  8. Dong, 2001, Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix, Clin. Cancer Res., 7, 1982
  9. Duffy, 2003, Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6, Virology, 314, 196, 10.1016/S0042-6822(03)00390-8 · DOI
  10. Dyson, 1992, Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins, J. Virol., 66, 6893, 10.1128/jvi.66.12.6893-6902.1992 · DOI · Paper page
  11. Eisen, 1998, Cluster analysis and display of genome-wide expression patterns, Proc. Natl. Acad. Sci. U. S. A., 95, 14863, 10.1073/pnas.95.25.14863 · DOI · Paper page
  12. Gilles, 1994, Differentiation ability and oncogenic potential of HPV-33− and HPV-33 + ras-transfected keratinocytes, Int. J. Cancer, 58, 847, 10.1002/ijc.2910580617 · DOI
  13. Gilles, 1994, Epithelial-to-mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A, Int. J. Cancer, 59, 661, 10.1002/ijc.2910590514 · DOI
  14. Gilles, 1996, Vimentin expression in cervical carcinomas: association with invasive and migratory potential, J. Pathol., 180, 175, 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G · DOI
  15. Goldberg, 1998, Expression of extracellular matrix proteins in cervical squamous cell carcinoma—a clinicopathological study, J. Clin. Pathol., 51, 781, 10.1136/jcp.51.10.781 · DOI
  16. Gonzalez, 2001, Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7, J. Virol., 75, 7583, 10.1128/JVI.75.16.7583-7591.2001 · DOI · Paper page
  17. Hagemann, 2007, Molecular profiling of cervical cancer progression, Br. J. Cancer, 96, 321, 10.1038/sj.bjc.6603543 · DOI
  18. Han, 2006, Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B, Oncogene, 25, 4341, 10.1038/sj.onc.1209460 · DOI
  19. Hazan, 1997, N-cadherin promotes adhesion between invasive breast cancer cells and the stroma, Cell. Adhes. Commun., 4, 399, 10.3109/15419069709004457 · DOI
  20. Hirohashi, 2003, Cell adhesion system and human cancer morphogenesis, Cancer Sci., 94, 575, 10.1111/j.1349-7006.2003.tb01485.x · DOI
  21. Howie, 2009, Papillomavirus E6 proteins, Virology, 384, 324, 10.1016/j.virol.2008.11.017 · DOI
  22. Irizarry, 2003, Summaries of Affymetrix GeneChip probe level data, Nucleic Acids Res., 31, e15, 10.1093/nar/gng015 · DOI
  23. Islam, 1996, Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell–cell adhesion, J. Cell. Biol., 135, 1643, 10.1083/jcb.135.6.1643 · DOI
  24. Jeanes, 2008, Cadherins and cancer: how does cadherin dysfunction promote tumor progression?, Oncogene, 27, 6920, 10.1038/onc.2008.343 · DOI
  25. Jones, 1997, Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein, J. Virol., 71, 2905, 10.1128/jvi.71.4.2905-2912.1997 · DOI · Paper page
  26. Jones, 1999, Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway, Virology, 258, 406, 10.1006/viro.1999.9733 · DOI · Paper page
  27. Kang, 2005, Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer, Gynecol. Oncol., 96, 173, 10.1016/j.ygyno.2004.09.031 · DOI
  28. Kiyono, 1997, Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein, Proc. Natl. Acad. Sci. U. S. A., 94, 11612, 10.1073/pnas.94.21.11612 · DOI · Paper page
  29. Klingelhutz, 1996, Telomerase activation by the E6 gene product of human papillomavirus type 16, Nature, 380, 79, 10.1038/380079a0 · DOI · Paper page
  30. Lee, 1997, Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein, Proc. Natl. Acad. Sci. U. S. A., 94, 6670, 10.1073/pnas.94.13.6670 · DOI · Paper page
  31. Lee, 2008, Epithelial–mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation, Clin. Cancer Res., 14, 4743, 10.1158/1078-0432.CCR-08-0234 · DOI
  32. Mani, 2008, The epithelial–mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 · DOI
  33. Martel, 1997, Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial–fibroblastoid conversion and invasiveness, Cell Growth Differ., 8, 165
  34. McLaughlin-Drubin, 2009, The human papillomavirus E7 oncoprotein, Virology, 384, 335, 10.1016/j.virol.2008.10.006 · DOI
  35. Michaels, 1998, Cluster analysis and data visualization of large-scale gene expression data, Pac. Symp. Biocomput., 42–53
  36. Munger, 1989, The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes, J. Virol., 63, 4417, 10.1128/jvi.63.10.4417-4421.1989 · DOI · Paper page
  37. Munger, 2004, Mechanisms of human papillomavirus-induced oncogenesis, J. Virol., 78, 11451, 10.1128/JVI.78.21.11451-11460.2004 · DOI · Paper page
  38. Narayan, 2003, Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome, Mol. Cancer, 2, 24, 10.1186/1476-4598-2-24 · DOI
  39. Piboonniyom, 2003, Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability, Cancer Res., 63, 476
  40. Rey, 2000, Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin, J. Virol., 74, 4912, 10.1128/jvi.74.10.4912-4918.2000 · DOI
  41. Riley, 2003, Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis, Cancer Res., 63, 4862
  42. Schaafsma, 1993, Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma, J. Pathol., 170, 77, 10.1002/path.1711700113 · DOI
  43. Scheffner, 1990, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell, 63, 1129, 10.1016/0092-8674(90)90409-8 · DOI · Paper page
  44. Shivapurkar, 2007, Evaluation of candidate methylation markers to detect cervical neoplasia, Gynecol. Oncol., 107, 549, 10.1016/j.ygyno.2007.08.057 · DOI
  45. Terra, 2007, Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III, Tumori, 93, 572, 10.1177/030089160709300610 · DOI
  46. Thiery, 2006, Complex networks orchestrate epithelial–mesenchymal transitions, Nat. Rev. Mol. Cell. Biol., 7, 131, 10.1038/nrm1835 · DOI
  47. Watson, 2003, Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes, J. Cell. Sci., 116, 4925, 10.1242/jcs.00809 · DOI
  48. Wen, 1998, Large-scale temporal gene expression mapping of central nervous system development, Proc. Natl. Acad. Sci. U. S. A., 95, 334, 10.1073/pnas.95.1.334 · DOI
  49. Yang, 2006, Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data, BMC Cancer, 6, 212, 10.1186/1471-2407-6-212 · DOI
  50. Zhang, 2006, The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation, Proc. Natl. Acad. Sci. U. S. A., 103, 437, 10.1073/pnas.0510012103 · DOI · Paper page
  51. zur Hausen, 2002, Papillomaviruses and cancer: from basic studies to clinical application, Nat. Rev. Cancer, 2, 342, 10.1038/nrc798 · DOI

Cited by

See all 94

Metadata

Authors
Hellner, K., Mar, J., Fang, F., Quackenbush, J., & Münger, K.
Venue
Virology
Publisher
Elsevier BV
Published
2009-08
Volume
391
Issue
1
Pages
57-63
ISSN
0042-6822
DOI
10.1016/j.virol.2009.05.036
PMC
PMC2728214
Cited by
94
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review